PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Lagos State Ministry of Health, Alausa, Ikeja, Lagos State, Nigeria.\', \'Lagos State Primary Health Care Board, Lagos, Nigeria.\', \'Nigerian Institute of Medical Research, Lagos, Nigeria.\', \'Lagos State University College of Medicine, Lagos, Nigeria.\', \'Lagos State University Teaching Hospital, Lagos, Nigeria.\', \'Lagos State Health Management Agency, Lagos, Nigeria.\', \'Lagos State Ministry of Health, Alausa, Ikeja, Lagos State, Nigeria. sea.anya@gmail.com.\']
?:citedBy
  • -1
?:creator
?:doi
?:doi
  • 10.1186/s13063-021-05675-x
?:hasPublicationType
?:journal
  • Trials
is ?:pmid of
?:pmid
?:pmid
  • 34863267
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • 1.291
?:rankingScore_hIndex
  • 57
?:title
  • A multi-centre, randomized, double-blind, placebo-controlled clinical trial of the efficacy and safety of chloroquine phosphate, hydroxychloroquine sulphate and lopinavir/ritonavir for the treatment of COVID-19 in Lagos State: study protocol for a randomized controlled trial.
?:type
?:year
  • 2021

Metadata

Anon_0  
expand all